• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
  • For Subscribers
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 96 of 100
JPMorgan Chase & Co. CEO Jamie Dimon Speaks At An Institute Of International Finance Panel
Features
ECB peps markets and JPMorgan shareholders vote on Dimon’s pay–5 things to know today
By Laura LorenzettiMay 19, 2015
157934085
Features
The pharma M&A party is still in full swing, as Endo snaps up Par
By Geoffrey SmithMay 18, 2015
BRITAIN-PHARMACEUTICAL-GSK
Tech
GlaxoSmithKline plans to work with U.S. scientists to develop a cure for AIDS
By ReutersMay 11, 2015
Biopharma deals are booming this year with no end in sight
Finance
Biopharma deals are booming this year with no end in sight
By Laura LorenzettiMay 8, 2015
Cancer drug spending hit $100 billion in 2014. Here’s why it’ll soon be much higher
Features
Cancer drug spending hit $100 billion in 2014. Here’s why it’ll soon be much higher
By Laura LorenzettiMay 8, 2015
J&J brings in ethicists to judge on requests for experimental drugs
Features
J&J brings in ethicists to judge on requests for experimental drugs
By ReutersMay 7, 2015
Inside of a Gilead Sciences Lab
Tech
Drugmaker Alexion boosts its rare drug pipeline with $8.4 billion deal
By ReutersMay 6, 2015
Clashes in Baltimore over death of Freddie Gray
Features
Baltimore riots, Google, and Twitter earnings — 5 things to know today
By Laura LorenzettiApril 28, 2015
Ontario Closer Than Ever To Legalization Of Marijuana
Leadership
How new blood in Washington, DC could impact the marijuana industry
By Tom Huddleston Jr.April 24, 2015
PA: Mylan Headquarters
Finance
Mylan plays monkey-in-the-middle of hostile takeover battles
By Jen WiecznerApril 21, 2015
PA: Mylan Headquarters
Finance
Teva offers to buy rival Mylan for $40 billion to create generics giant
By Laura LorenzettiApril 21, 2015
Newest Innovations In Consumer Technology On Display At 2014 International CES
Features
EU goes after Gazprom, and Teva eyes Mylan — 5 things to know today
By Laura LorenzettiApril 21, 2015
pancreatic cancer cell
Tech
How one company is using artificial intelligence to develop a cure for cancer
By Cyrus SanatiApril 16, 2015
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
Features
Americans spent a record amount on medicine in 2014
By TIMEApril 14, 2015
IL: Corporations In Illinois
Finance
Hospira hit with further FDA scrutiny after $17 billion Pfizer deal
By Laura LorenzettiApril 8, 2015
1...
  • 94
  • 95
  • 96
  • 97
  • 98
...100
Most Popular
Personal Finance
Social Security has less than 6 years before a 22% cut. A Senate chairman’s fix is to borrow $190 trillion and call it the ‘Stop Scaring Seniors Act’placeholder alt text
By Nick LichtenbergNovember 19, 2026
Big Tech
Sound Ventures turned $435 million into a $7 billion Anthropic stake. Ashton Kutcher left months before the IPOplaceholder alt text
By Steven JohnNovember 19, 2026
Cybersecurity
‘This, I’m sorry to say, is just the opening chapter’: Top cyber expert warns of a ‘vulnpocalypse’ after 4 major U.S. systems broke in 6 daysplaceholder alt text
By Nick LichtenbergNovember 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.